Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Juneja

Showing results (191-200 of 195) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 195 results.
Cell|December 10, 2020
Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor ImmunityAlison E Ringel, Jefte M Drijvers, Gregory J Baker, et al.
Nature Medicine|January 3, 2025
Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trialJessica S W Borgers, Divya Lenkala, Victoria Kohler, et al.
Nature Medicine|August 5, 2025
Publisher Correction: Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trialJessica S W Borgers, Divya Lenkala, Victoria Kohler, et al.
Science Translational Medicine|February 18, 2021
Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responsesJennifer A Lo, Masayoshi Kawakubo, Vikram R Juneja, et al.
Nature Communications|February 5, 2026
NEO-STIM advances personalized neoantigen-specific adoptive T cell therapyDivya Lenkala, Jessica Kohler, Brian McCarthy, et al.
Pageof 20

Showing results (191-200 of 195) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 195 results.
Cell|December 10, 2020
Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor ImmunityAlison E Ringel, Jefte M Drijvers, Gregory J Baker, et al.
Nature Medicine|January 3, 2025
Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trialJessica S W Borgers, Divya Lenkala, Victoria Kohler, et al.
Nature Medicine|August 5, 2025
Publisher Correction: Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trialJessica S W Borgers, Divya Lenkala, Victoria Kohler, et al.
Science Translational Medicine|February 18, 2021
Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responsesJennifer A Lo, Masayoshi Kawakubo, Vikram R Juneja, et al.
Nature Communications|February 5, 2026
NEO-STIM advances personalized neoantigen-specific adoptive T cell therapyDivya Lenkala, Jessica Kohler, Brian McCarthy, et al.
Pageof 20